Results 141 to 150 of about 506,611 (220)

Genomic features of pneumococcal strains isolated from paediatric patients with invasive disease during pneumococcal conjugate vaccine introduction in Lima, Peru. [PDF]

Microb Genom
Gonzales BE, Durand D, Mercado EH, Lopez-Briceño M, González L, Grupo Peruano de Investigación En Neumococo Gpin, Ochoa TJ.   +6 more
europepmc   +1 more source

Cost-effectiveness and return on investment of 20-valent pneumococcal conjugate vaccine use among adults in England: analysis from the societal perspective. [PDF]

Cost Eff Resour Alloc
Mendes D, Averin A, Atwood M, Sato R, Vyse A, Campling J, Hariharan D, Weycker D, Mugwagwa T, Vietri J.   +9 more
europepmc   +1 more source

Evaluation of efficacy and effectiveness across the pneumococcal conjugate vaccine era. [PDF]

Hum Vaccin Immunother
LaFon DC.
europepmc   +1 more source

Effectiveness of 10-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia and invasive pneumococcal disease among young children in Mozambique. [PDF]

Vaccine
Sigaúque B, Vilanculos L, Chaúque A, Moiane B, Mucavele H, Massora S, Acácio S, Sacoor C, Quintó L, Matsinhe B, Pimenta F, Whitney CG, Lessa FC, da Glória Carvalho M, Verani JR.   +14 more
europepmc   +1 more source

Cross reactivity within pneumococcal serogroups 6 and 15 following adult vaccination with pneumococcal conjugate vaccine V116. [PDF]

Commun Med (Lond)
Li J, Platt HL, Hu W, Xu W, Chapman TJ, Nolan KM, Hartzel J, Buchwald UK.   +7 more
europepmc   +1 more source

Association between introduction of 13-valent pneumococcal conjugate vaccine and burden of hospitalized adult pneumococcal disease in Hong Kong - A retrospective database study. [PDF]

Hum Vaccin Immunother
Yu Q, Chui CSL, Yeo SH, Patel D, Lim CTK, Li X, Chan VKY, Yamada E, Sukarom I.   +8 more
europepmc   +1 more source

Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine Versus a 13-Valent Vaccine in Infants: A Systematic Review and Meta-Analysis. [PDF]

Vaccines (Basel)
Pacheco-Haro MD, de Arenas-Arroyo SN, Díaz-Goñi V, Velasco-Lucio EJ, Castellares-González CI, Reynolds-Cortez V, Simeón-Prieto A, Ignateva E, Martínez-Vizcaíno V.   +8 more
europepmc   +1 more source

Assessing the Impact of Pneumococcal Conjugate Vaccines

Clinical Infectious Diseases, 2019
openaire   +2 more sources

Immunogenicity and safety of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults ≥18 years of age in India: A phase 3 single-arm trial. [PDF]

Hum Vaccin Immunother
Giriappa B, Choraria N, Ponce P, Drozd J, Su X, Lei L, Portka M, Pai S, Anderson A, Bickham K, Watson W, McElwee K.   +11 more
europepmc   +1 more source

Safety and Immunogenicity of SII's 10-Valent Pneumococcal Conjugate Vaccine (PCV10-SII) in Vietnamese Children Aged from 6 Weeks to 24 Months: An Open-Label, Single-Arm Bridging Study. [PDF]

Vaccines (Basel)
Son VT, Anh BDT, Hoan VN, Than HV, Linh BK, Giang TH, Manh NT, Thao LTT, Cuong HX, Giang DT, Dat DT, Giang LTH, Mulay SC, Sethna V, Hung PV.   +14 more
europepmc   +1 more source